Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580065 | PMC |
http://dx.doi.org/10.3389/fnins.2023.1244064 | DOI Listing |
Clin Pharmacokinet
January 2025
Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
The rise in global obesity prevalence has increased the need to understand the pharmacokinetics of drugs in overweight and obese individuals. Tuberculosis remains a significant health challenge, and its treatment outcomes can be influenced by the pharmacokinetic profiles of antitubercular agents. This literature review aims to point out the clinical pharmacokinetics of antitubercular drugs in the overweight and obese patient population, highlighting considerations for potential dosage adjustments.
View Article and Find Full Text PDFObes Surg
January 2025
Iran University of Medical Sciences, Tehran, Islamic Republic of Iran.
Obes Surg
January 2025
Department of Surgery, University of Oklahoma College of Community Medicine, Tulsa, Oklahoma, USA.
The obesity rate is increasing worldwide despite various policies and efforts. However, there is a concern with underrecording and underreporting of obesity in outpatient and inpatient settings which can affect patient care. Local and national reports based on medical records can provide an underestimated rate of obesity.
View Article and Find Full Text PDFCirc Cardiovasc Qual Outcomes
January 2025
Food is Medicine Institute, Friedman School of Nutrition Science and Policy, and Tufts University School of Medicine, Tufts University, Boston, MA.
Front Endocrinol (Lausanne)
December 2024
Frank H. Netter MD School of Medicine, Quinnipiac University, North Haven, CT, United States.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!